Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  87 نتائج ل ""Proto-Oncogene Proteins B-raf""

فلترة النتائج

Publication : cancer medicine
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A large-scale, multicenter characterization of BRAF G469V/A-mutant non-small cell lung cancer.

  • Authors : Wu H; Department of Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Feng J

Subjects: Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (10), pp. e7305.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study).

  • Authors : Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Ito T

Subjects: Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/genetics

  • Source: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17967-17980. Date of Electronic Publication: 2023 Aug 16.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer.

  • Authors : Xu T; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.; Li J

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics; Humans

  • Source: Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10473-10484. Date of Electronic Publication: 2023 Mar 13.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancer.

  • Authors : Offermans K; Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Jenniskens JCA

Subjects: Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics; Humans Turcot syndrome

  • Source: Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (2), pp. 1137-1156. Date of Electronic Publication: 2022 Jul 03.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF-mutant advanced melanoma treated with first-line anti-PD-1 monotherapies or BRAF/MEK inhibitors in a community-based oncology setting.

  • Authors : Cowey CL; Texas Oncology Baylor Charles A Sammons Cancer Center, Dallas, TX, USA.; McKesson Life Sciences, The Woodlands, TX, USA.

Subjects: Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/Immune Checkpoint Inhibitors/*therapeutic use ; MAP Kinase Kinase Kinases/MAP Kinase Kinase Kinases/MAP Kinase Kinase Kinases/*antagonists & inhibitors ; Melanoma/Melanoma/Melanoma/*drug therapy

  • Source: Cancer medicine [Cancer Med] 2020 Nov; Vol. 9 (21), pp. 7863-7878. Date of Electronic Publication: 2020 Sep 01.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.

  • Authors : Kopecký J; Department of Clinical Radiotherapy and Oncology, University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.; Pásek M

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/genetics ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e6982.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab.

  • Authors : Moser JC; HonorHealth Research Institute, Scottsdale, AZ, USA.; Chen D

Subjects: Mutation*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Melanoma/Melanoma/Melanoma/*drug therapy

  • Source: Cancer medicine [Cancer Med] 2019 Dec; Vol. 8 (18), pp. 7637-7643. Date of Electronic Publication: 2019 Nov 02.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.

  • Authors : Li N; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.; Lin P

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Hematopoietic Stem Cell Transplantation*

  • Source: Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (13), pp. 14293-14304. Date of Electronic Publication: 2023 May 22.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Targeted therapy in lung cancer: Are we closing the gap in years of life lost?

Subjects: Humans; Carcinoma; Non-Small-Cell Lung

  • Source: Cancer medicine. 11(18)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Prognostic value of Lynch syndrome, BRAF V600E , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts.

  • Authors : Zwart K; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; van der Baan FH

Subjects: Colorectal Neoplasms, Hereditary Nonpolyposis*/Colorectal Neoplasms, Hereditary Nonpolyposis*/Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colonic Neoplasms*

  • Source: Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 15841-15853. Date of Electronic Publication: 2023 Jun 16.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  87 نتائج ل ""Proto-Oncogene Proteins B-raf""